Klaus Hirschbühl

1.1k total citations · 1 hit paper
16 papers, 487 citations indexed

About

Klaus Hirschbühl is a scholar working on Infectious Diseases, Hematology and Oncology. According to data from OpenAlex, Klaus Hirschbühl has authored 16 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Hematology and 4 papers in Oncology. Recurrent topics in Klaus Hirschbühl's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Acute Myeloid Leukemia Research (3 papers). Klaus Hirschbühl is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Acute Myeloid Leukemia Research (3 papers). Klaus Hirschbühl collaborates with scholars based in Germany, United States and Netherlands. Klaus Hirschbühl's co-authors include Bruno Märkl, Tina Schaller, Rainer Claus, Katrin Burkhardt, Martin Trepel, Georg Braun, Katharina Endhardt, Christine Dhillon, Gerhard Schenkirsch and Sebastian Dintner and has published in prestigious journals such as JAMA, Blood and PLoS ONE.

In The Last Decade

Klaus Hirschbühl

14 papers receiving 479 citations

Hit Papers

Postmortem Examination of Patients With COVID-19 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Postmortem Examination of Patients With COVID-19
    2020 375 citations Tina Schaller, Klaus Hirschbühl et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Hirschbühl Germany 7 324 204 116 70 44 16 487
Maria Mostyka United States 6 309 1.0× 167 0.8× 73 0.6× 111 1.6× 33 0.8× 10 445
Hasti Robbie United Kingdom 8 223 0.7× 103 0.5× 109 0.9× 120 1.7× 39 0.9× 13 459
Moreno Tresoldi Italy 3 258 0.8× 133 0.7× 86 0.7× 58 0.8× 30 0.7× 3 354
Herbert Mushumba Germany 10 290 0.9× 123 0.6× 169 1.5× 28 0.4× 10 0.2× 20 473
Michelle McDonald United States 4 241 0.7× 124 0.6× 70 0.6× 38 0.5× 12 0.3× 10 320
Abdullah Balhamar Saudi Arabia 11 250 0.8× 174 0.9× 62 0.5× 86 1.2× 84 1.9× 18 440
Meng Cao United States 4 229 0.7× 205 1.0× 80 0.7× 19 0.3× 21 0.5× 7 321
Thibaut Fabacher France 11 172 0.5× 123 0.6× 86 0.7× 48 0.7× 24 0.5× 34 354
Ana Paula Moreira Salles Brazil 5 177 0.5× 99 0.5× 65 0.6× 19 0.3× 13 0.3× 7 302
Emanuela Barisione Italy 11 107 0.3× 88 0.4× 76 0.7× 142 2.0× 29 0.7× 34 319

Countries citing papers authored by Klaus Hirschbühl

Since Specialization
Citations

This map shows the geographic impact of Klaus Hirschbühl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Hirschbühl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Hirschbühl more than expected).

Fields of papers citing papers by Klaus Hirschbühl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Hirschbühl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Hirschbühl. The network helps show where Klaus Hirschbühl may publish in the future.

Co-authorship network of co-authors of Klaus Hirschbühl

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Hirschbühl. A scholar is included among the top collaborators of Klaus Hirschbühl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Hirschbühl. Klaus Hirschbühl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fraccaroli, Alessia, Vindi Jurinović, Klaus Hirschbühl, et al.. (2025). Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation. Blood Advances. 9(7). 1630–1641. 3 indexed citations
2.
Schmohl, Joerg Uwe, Andreas Rank, Klaus Hirschbühl, et al.. (2024). In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers. International Journal of Molecular Sciences. 25(24). 13469–13469. 3 indexed citations
3.
Schweizer, Lisa, Tina Schaller, Maximilian Zwiebel, et al.. (2023). Quantitative multiorgan proteomics of fatal COVID‐19 uncovers tissue‐specific effects beyond inflammation. EMBO Molecular Medicine. 15(9). e17459–e17459. 13 indexed citations
4.
5.
Dintner, Sebastian, Klaus Hirschbühl, Rainer Claus, et al.. (2023). NGS-basierte Molekulargenetik der Leukämie – ein leistungsfähiger und dezentraler Lösungsansatz. PubMed. 44(S3). 155–159.
6.
Märkl, Bruno, Sebastian Dintner, Tina Schaller, et al.. (2022). Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study. International Journal of Infectious Diseases. 128. 51–57. 3 indexed citations
7.
8.
Fraccaroli, Alessia, Klaus Hirschbühl, Frank Ziemann, et al.. (2022). Presence of Measurable Residual Disease in NPM1 Positive AML in Remission Pre-Transplant Does Not Impact on Survival after Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 140(Supplement 1). 4882–4883. 1 indexed citations
9.
Grosser, Bianca, Tina Schaller, Klaus Hirschbühl, et al.. (2021). Impaired Dendritic Cell Homing in COVID-19. Frontiers in Medicine. 8. 761372–761372. 9 indexed citations
10.
Hirschbühl, Klaus, Sebastian Dintner, Martin Beer, et al.. (2021). Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approach. PLoS ONE. 16(7). e0254872–e0254872. 16 indexed citations
11.
Wylezich, Claudia, Tina Schaller, Rainer Claus, et al.. (2021). Whole-genome analysis of SARS-CoV-2 samples indicate no tissue specific genetic adaptation of the virus in COVID-19 patients’ upper and lower respiratory tract. Diagnostic Microbiology and Infectious Disease. 101(4). 115520–115520. 3 indexed citations
12.
13.
Schaller, Tina, Klaus Hirschbühl, Katrin Burkhardt, et al.. (2020). Postmortem Examination of Patients With COVID-19. JAMA. 323(24). 2518–2518. 375 indexed citations breakdown →
14.
Schaller, Tina, Boris Kubuschok, Klaus Hirschbühl, et al.. (2019). Periodisches Fieber und Panzytopenie bei einem 35‑jährigen Patienten. Der Internist. 60(12). 1305–1310. 1 indexed citations
15.
Märkl, Bruno, Klaus Hirschbühl, & Christine Dhillon. (2019). NTRK-Fusions – A new kid on the block. Pathology - Research and Practice. 215(10). 152572–152572. 13 indexed citations
16.
Märkl, Bruno, et al.. (2015). Lymph node size as a simple prognostic factor in node negative colon cancer and an alternative thesis to stage migration. The American Journal of Surgery. 212(4). 775–780. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Mostyka Breakdown of academic impact, for papers by Hasti Robbie Breakdown of academic impact, for papers by Moreno Tresoldi Breakdown of academic impact, for papers by Herbert Mushumba Breakdown of academic impact, for papers by Michelle McDonald Breakdown of academic impact, for papers by Abdullah Balhamar Breakdown of academic impact, for papers by Meng Cao Breakdown of academic impact, for papers by Thibaut Fabacher Breakdown of academic impact, for papers by Ana Paula Moreira Salles Breakdown of academic impact, for papers by Emanuela Barisione
Rankless by CCL
2026